Request page removalAbout Thomas Teichman
Thomas Teichman is an angel investor and a board member based out of London, United Kingdom. Their journey in the startup ecosystem started in 2016 through Simba. As an angel investor, Thomas Teichman has a portfolio of 2 companies, focusing primarily on sectors like Retail, Consumer and 2 more sectors. They invest in companies across United Kingdom. Their most notable investments are Mergermarket and Simba. Thomas Teichman is currently serving as a board member at Simba and Doctify.
Key Metrics
Thomas Teichman's Investments
Thomas Teichman has invested in 2 companies, which was in Simba (Series A Round) on Oct 12, 2016. Their investments are primarily in Retail, Consumer and 2 more sectors. Their investment portfolio companies are located in United Kingdom.Here is the detail of this recent investment:
Date | Company | Round | Round Amount | Co-Investors |
|---|---|---|---|---|
Oct 12, 2016 | Series A | $6.14M |
Want to explore profiles similar to Thomas Teichman?
Let us walk you through our investor database and other offerings.
Let us walk you through our investor database and other offerings.
Thomas Teichman's Portfolio Exits
Thomas Teichman has 1 Portfolio Exit which is Mergermarket.
Here is the detail of this portfolio exit:
Company | Description | Location | Total Funding | Founded Year | Exit Type | Exit Date |
|---|---|---|---|---|---|---|
M&A intelligence, analysis, and news platform | London (United Kingdom) | $5.38M | 1999 | Acquisition | Nov 29, 2013 |
Thomas Teichman's Board Memberships
Thomas Teichman has 2 current board memberships namely Simba and Doctify.Here are the details of all board memberships by Thomas Teichman:
Company | Description | Total Funding | Current Stage | Membership Status | Appointment Date | Cessation Date |
|---|---|---|---|---|---|---|
Manufacturer of mattresses beds pillows duvets toppers and sleep accessories | $229M | Series B | CURRENT | Feb 20, 2016 | - | |
Online platform for finding and booking verified healthcare providers based on patient reviews | $29.9M | Series B | CURRENT | Sep 12, 2018 | - |
FAQs about Thomas Teichman
Recently updated other profiles
